GNI Group Ltd.

Insider Reports History

Location
Tokyo, Japan
Signature
/s/ Branden Berns, as attorney-in-fact for GNI Group Ltd.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by GNI Group Ltd.:

Company Role Class Num Shares Value Price $ Report Date Ownership
GYRE THERAPEUTICS, INC. 10%+ Owner Common Stock 64,005,887 $30,082,767 $0.4700 30 Oct 2023 See Remarks
GYRE THERAPEUTICS, INC. 10%+ Owner Series X Convertible Preferred Stock Warrant (Right to Buy) 8,110,300 $1,013,788 $0.1250 27 Oct 2023 Indirect
GYRE THERAPEUTICS, INC. 10%+ Owner Series X Convertible Preferred Stock 13,151 27 Oct 2023 Indirect
CATALYST BIOSCIENCES, INC. 10%+ Owner Series Y Preferred Stock 0 31 Aug 2023 Direct

Insider Reports Filed by GNI Group Ltd.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GYRE GYRE THERAPEUTICS, INC. 30 Oct 2023 1 $0 4 10%+ Owner 22 Nov 2023, 19:27
GYRE GYRE THERAPEUTICS, INC. 27 Oct 2023 2 +$4,999,852 4 10%+ Owner 31 Oct 2023, 21:56
GYRE CATALYST BIOSCIENCES, INC. 27 Oct 2023 0 $0 3 10%+ Owner 27 Oct 2023, 20:01
GYRE CATALYST BIOSCIENCES, INC. 31 Aug 2023 2 $0 4 10%+ Owner 01 Sep 2023, 16:07
GYRE CATALYST BIOSCIENCES, INC. 26 Dec 2022 0 $0 3 10%+ Owner 05 Jan 2023, 15:06